Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 28, 2011; 17(44): 4917-4921
Published online Nov 28, 2011. doi: 10.3748/wjg.v17.i44.4917
Published online Nov 28, 2011. doi: 10.3748/wjg.v17.i44.4917
Variables | Recurrence | P value | |
No | Yes | ||
Age (yr) | 0.804 | ||
< 63 | 31 | 10 | |
≥ 63 | 29 | 11 | |
Gender | 0.569 | ||
Female | 16 | 4 | |
Male | 44 | 17 | |
Smoking | 0.614 | ||
No | 31 | 9 | |
Yes | 29 | 12 | |
Drinking | 0.799 | ||
No | 26 | 8 | |
Yes | 34 | 13 | |
Operation | 0.614 | ||
No | 38 | 12 | |
Yes | 22 | 9 | |
Chemo-/radio-therapy | 0.751 | ||
No | 11 | 5 | |
Yes | 49 | 16 | |
Stage | < 0.001 | ||
I | 25 | 3 | |
II | 22 | 3 | |
III | 13 | 15 |
- Citation: Liu JB, Qiang FL, Dong J, Cai J, Zhou SH, Shi MX, Chen KP, Hu ZB. Plasma DNA methylation of Wnt antagonists predicts recurrence of esophageal squamous cell carcinoma. World J Gastroenterol 2011; 17(44): 4917-4921
- URL: https://www.wjgnet.com/1007-9327/full/v17/i44/4917.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i44.4917